Post date April 2, 2024 Experience Stoke Therapeutics $125 million stock and pre-funded warrants offering The common stock is listed on the Nasdaq Global Select Market
Post date March 19, 2024 Experience Cleveland-Cliffs $825 million notes offering and concurrent tender offer The high-yield notes are due 2032
Post date March 8, 2024 Experience GFL Environmental $723.45 million secondary offering The subordinate voting shares are dual-listed on the NYSE and the Toronto Stock Exchange
Post date March 4, 2024 Experience Aon $6 billion senior notes offering The investment-grade offering comprises five tranches
Post date February 21, 2024 Experience Amer Sports $800 million senior secured notes offering We advised Amer Sports on the high-yield notes offering
Post date February 16, 2024 Experience Amer Sports $1.2 billion credit facilities and €700 million credit facility We advised the borrowers on the financing transactions
Post date February 12, 2024 Experience Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics We are advising Gilead Sciences on the acquisition
Post date February 8, 2024 Experience Azul $148.7 million secured notes reopening The senior secured notes are due 2028
Post date February 1, 2024 Experience Amer Sports $1.37 billion IPO We advised Amer Sports on its IPO and NYSE listing
Post date January 19, 2024 Experience Province of Ontario $3 billion global bond offering The investment-grade bonds are due 2029